Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
When using the hd120 mlc for beam shaping and under specific treatment conditions dose may be delivered outside of the intended treatment field that exceeds the expected transmission dose. this dosimetric property which has been discovered under very specific use conditions with dynamic fields and the hd120 mlc can lead to dose values significantly higher than expected in areas several centimeters away from the edge of the field. the effect is detectable for static mlc cases but only dynamic mlc (imrt) cases were considered to have any potential for significant unexpected dose.